Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose

RJ Keizer, MO Karlsson… - CPT: pharmacometrics & …, 2013 - Wiley Online Library
Several software tools are available that facilitate the use of the NONMEM software and
extend its functionality. This tutorial shows how three commonly used and freely available …

The role of population PK–PD modelling in paediatric clinical research

RFW De Cock, C Piana, EHJ Krekels, M Danhof… - European journal of …, 2011 - Springer
Children differ from adults in their response to drugs. While this may be the result of changes
in dose exposure (pharmacokinetics [PK]) and/or exposure response (pharmacodynamics …

Basic concepts in population modeling, simulation, and model‐based drug development—part 2: introduction to pharmacokinetic modeling methods

DR Mould, RN Upton - CPT: pharmacometrics & systems …, 2013 - Wiley Online Library
Population pharmacokinetic models are used to describe the time course of drug exposure
in patients and to investigate sources of variability in patient exposure. They can be used to …

Model evaluation of continuous data pharmacometric models: metrics and graphics

THT Nguyen, MS Mouksassi, N Holford… - CPT …, 2017 - Wiley Online Library
This article represents the first in a series of tutorials on model evaluation in nonlinear mixed
effect models (NLMEMs), from the International Society of Pharmacometrics (ISoP) Model …

Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions

RM Savic, MO Karlsson - The AAPS journal, 2009 - Springer
Abstract Empirical Bayes (“post hoc”) estimates (EBEs) of ηs provide modelers with
diagnostics: the EBEs themselves, individual prediction (IPRED), and residual errors …

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R

E Comets, K Brendel, F Mentré - Computer methods and programs in …, 2008 - Elsevier
Pharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-effect
models, and model evaluation should be an important part of the analysis. Recently …

NONMEM tutorial part II: estimation methods and advanced examples

RJ Bauer - CPT: pharmacometrics & systems pharmacology, 2019 - Wiley Online Library
In this second tutorial on NONMEM, the examples of typical pharmacokinetic/
pharmacodynamic modeling problems that occur in the pharmaceutical field will be …

Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients

TPC Dorlo, PPAM van Thiel, ADR Huitema… - Antimicrobial agents …, 2008 - Am Soc Microbiol
The pharmacokinetics of miltefosine in leishmaniasis patients are, to a great extent,
unknown. We examined and characterized the pharmacokinetics of miltefosine in a group of …

Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function

JK Duong, SS Kumar, CM Kirkpatrick… - Clinical …, 2013 - Springer
Abstract Background and Objective Metformin is contraindicated in patients with renal
impairment; however, there is poor adherence to current dosing guidelines. In addition, the …

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients

T Sasaki, H Takane, K Ogawa, S Isagawa… - Antimicrobial agents …, 2011 - Am Soc Microbiol
Linezolid is an antimicrobial agent to treat infections by Gram-positive pathogens, including
methicillin-resistant Staphylococcus aureus (MRSA). While effective, linezolid treatment …